Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Lett. 2012 Jun 28;319(2):136-43. doi: 10.1016/j.canlet.2011.12.042. Epub 2012 Jan 17.

A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth.

Author information

  • 1Department of Biochemistry, The University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA. gbidwell@umc.edu

Abstract

Although surgical resection with adjuvant chemotherapy and/or radiotherapy are used to treat breast tumors, normal tissue tolerance, development of metastases, and inherent tumor resistance to radiation or chemotherapy can hinder a successful outcome. We have developed a thermally responsive polypeptide, based on the sequence of Elastin-like polypeptide (ELP), that inhibits breast cancer cell proliferation by blocking the activity of the oncogenic protein c-Myc. Following systemic administration, the ELP - delivered c-Myc inhibitory peptide was targeted to tumors using focused hyperthermia, and significantly reduced tumor growth in an orthotopic mouse model of breast cancer. This work provides a new modality for targeted delivery of a specific oncogene inhibitory peptide, and this strategy may be expanded for delivery of other therapeutic peptides or small molecule drugs.

Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

PMID:
22261328
[PubMed - indexed for MEDLINE]
PMCID:
PMC3536021
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk